Abstract
The article presents a clinical case of an unclassifiable myeloproliferative neoplasm in a 65-year old patient. Platelet count is not a criteria for differential diagnosis of reactive and tumor processes. A typical course of the disease is associated with the persistence of symptoms of microcirculation disorder against the background of previous asymptomic thrombocytosis for several years. The diagnosis of an unclassifiable myeloproliferative neoplasm is established by a combination of clinical, laboratory, instrumental, molecular genetic and morphological methods of research.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference8 articles.
1. Melikyan AL, Kovrigina AM, Subortseva IN, et al. National clinical guidelines for the diagnosis and treatment of Ph-negative myeloproliferative diseases (polycythemia vera, essential thrombocythemia, primary myelofibrosis) (Edition 2020). Clinical oncohematology. 2021;14(2):264–298. (In Russ.)
2. Abdulkadyrov KM, Shuvaev VA, Martynkevich IS, et al. Modern concept of diagnosis and management of essential thrombocytemia. Bulletin of Hematology. 2014;10(1):4–33. (In Russ.)
3. Bogdanov AN, Tyrenko VV, Noskov YA, Semelev VN. Differentsial’naya diagnostika trombotsitozov v klinicheskoi praktike. Bulletin of the Russian Military Medical Academy. 2014;46(2):44–50. (In Russ.)
4. Sokolova NA. Differentsial’naya diagnostika trombotsitozov. In: Gematologicheskie issledovaniya i laboratornoe obespechenie transfuziologii (prakticheskoe posobie). 2015. P. 2–15.
5. Thrombocytosis as a cause of thrombohemorrhagic complications in the practice of a nephrologiste